Cellular Intelligence, a rapidly emerging biotech startup formerly known as Somite AI, has secured global rights to a clinical-stage Parkinson’s…
Read More
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s.
A significant stride in the realm of integrated medicine has been reported by Remepy, a pioneering startup, as its innovative…
Read More
Tubulin Acts as a Molecular Chaperone to Prevent Toxic Protein Aggregation in Alzheimer’s and Parkinson’s Disease Research
Scientists at the Baylor College of Medicine have announced a significant breakthrough in the understanding of neurodegenerative pathologies, identifying a…
Read More
Novo Nordisk Transfers Parkinson’s Cell Therapy to Cellular Intelligence, Signaling New Era for AI-Driven Biopharma
In a significant development for the burgeoning field of cell therapy and artificial intelligence in drug discovery, Cellular Intelligence, a…
Read More
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
In a significant advancement for integrated medicine, Remepy, a pioneering startup, has announced successful Phase IIa clinical trial results for…
Read More
Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior
Cellular Intelligence, a burgeoning biotechnology firm formerly known as Somite AI, has announced a significant strategic acquisition, securing global rights…
Read More
Researchers block key protein that helps Parkinson’s spread through the brain
Researchers at the Perelman School of Medicine at the University of Pennsylvania have uncovered a critical biological mechanism that may…
Read More
Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior
Cellular Intelligence, a rapidly emerging biotech firm previously known as Somite AI, has secured global rights to a pioneering clinical-stage…
Read More
A Noninvasive Treatment Offers Relief for Parkinson’s Disease Symptoms
The development of noninvasive treatments for Parkinson’s disease represents a significant stride in managing a neurodegenerative disorder that affects millions…
Read More
Novo Nordisk Hands a Parkinson’s Cell Therapy to Cellular Intelligence, a Startup Trying to Design Cell Behavior
In a significant move poised to reshape the landscape of Parkinson’s disease treatment and the broader cell therapy sector, Cellular…
Read MoreYOU MAY HAVE MISSED
